Company intelligence / Profile preview
Generate Biomedicines
Somerville, Massachusetts, United Statesgeneratebiomedicines.com ↗
- Ownership
- Public · GENB
- Development stage
- Phase 1
01
Overview
The company’s lead programs have demonstrated promising early clinical results. Notably, GB‑0669—the first AI-generated viral neutralizing antibody—achieved positive Phase I data against SARS-CoV‑2. GB‑0895 has completed a Phase I trial in mild-to-moderate asthma patients. Additional programs are advancing toward or into clinical trials across immunology and infectious disease.
- Therapeutic areas
- GastroenterologyPulmonologyDermatologyOncologyInfectious Diseases
- Modalities
- Monoclonal antibodies (mAbs)PeptidesEnzymesCytokinesModular proteinsCAR-T cell therapiesAntibody-drug conjugates (ADCs)
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
Amgen (multi-target collaboration)Novartis (multi-program collaboration)University of Texas MD Anderson Cancer Center
04
Financials
- Market cap
- $1.6B
- Total revenue
- $31.9M
- Enterprise value
- $1.2B
Beyond the preview
Go deeper on Generate Biomedicines.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Generate Biomedicines.